114 related articles for article (PubMed ID: 1919650)
41. Multi-pronged proteomic analysis to study the glioma pathobiology using cerebrospinal fluid samples.
Gahoi N; Malhotra D; Moiyadi A; Varma SG; Gandhi MN; Srivastava S
Proteomics Clin Appl; 2018 May; 12(3):e1700056. PubMed ID: 28679024
[TBL] [Abstract][Full Text] [Related]
42. Mucin-like carcinoma associated antigen (MCA) at presentation with breast cancer.
Horgan PG; Byrne J; O'Donoghue J; Mooney E; Grimes H; Given HF
Ir J Med Sci; 1997; 166(4):215-6. PubMed ID: 9394068
[TBL] [Abstract][Full Text] [Related]
43. Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor.
Nakagawa H; Fujita T; Kubo S; Tokiyoshi K; Yamada M; Kanayama T; Hagiwara Y; Nakanomyo H; Hiraoka M
Cancer Chemother Pharmacol; 1996; 37(4):317-26. PubMed ID: 8548876
[TBL] [Abstract][Full Text] [Related]
44. [Multiple cerebral glioma or tumor dissemination via CSF pathways? Case report].
Czepko R; Kwinta B; Adamek D; Uhl H; Betlej M; Lopatka P
Neurol Neurochir Pol; 2003; 37(6):1307-15. PubMed ID: 15174243
[TBL] [Abstract][Full Text] [Related]
45. Uses and limitations of prostate-specific antigen in the laboratory diagnosis of prostate cancer.
Wells DJ; Bennett BD; Gardner WA
South Med J; 1988 Feb; 81(2):218-20. PubMed ID: 2448884
[TBL] [Abstract][Full Text] [Related]
46. [Markers of brain tumors].
Fumagalli R; Pezzotta S; Bernini F; Racagni G
Minerva Med; 1984 May; 75(21):1271-8. PubMed ID: 6203056
[TBL] [Abstract][Full Text] [Related]
47. Choroid plexus papilloma in infancy.
Yadav S; Dubey AP
Indian Pediatr; 1993 Oct; 30(10):1217-8. PubMed ID: 8077013
[No Abstract] [Full Text] [Related]
48. Assessment of tumor markers in cerebrospinal fluid.
Jaeckle KA
Clin Lab Med; 1985 Jun; 5(2):303-15. PubMed ID: 2411459
[TBL] [Abstract][Full Text] [Related]
49. Interleukin-13 conjugated quantum dots for identification of glioma initiating cells and their extracellular vesicles.
Madhankumar AB; Mrowczynski OD; Patel SR; Weston CL; Zacharia BE; Glantz MJ; Siedlecki CA; Xu LC; Connor JR
Acta Biomater; 2017 Aug; 58():205-213. PubMed ID: 28583903
[TBL] [Abstract][Full Text] [Related]
50. [Clinical significance of beta 2-microglobulin and carcinoembryonic antigen in intracranial tumors].
Suzuki Y; Ishii R; Otsuka R; Ogawa Y; Kikuoka M; Hirano K; Tanaka R
No To Shinkei; 1987 Oct; 39(10):965-70. PubMed ID: 3325088
[TBL] [Abstract][Full Text] [Related]
51. Long non-coding RNAs: potential molecular biomarkers for gliomas diagnosis and prognosis.
Wang L; Yu Z; Sun S; Peng J; Xiao R; Chen S; Zuo X; Cheng Q; Xia Y
Rev Neurosci; 2017 May; 28(4):375-380. PubMed ID: 28107175
[TBL] [Abstract][Full Text] [Related]
52. Preparation and characterization of antisera and of murine monoclonal antibodies to human glioma-associated antigen(s).
Matsuda M; Fischer DK; Narayan RK; Atassi MZ
Adv Exp Med Biol; 1991; 303():271-83. PubMed ID: 1805572
[TBL] [Abstract][Full Text] [Related]
53. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125.
Verlooy H; Devos P; Janssens J; Mortelmans L; Gerits M; Bonte J; De Roo M
Gynecol Obstet Invest; 1991; 32(1):55-8. PubMed ID: 1765320
[TBL] [Abstract][Full Text] [Related]
54. Meningeal gliomatosis with "negative" CSF cytology: the value of GFAP staining.
Wechsler LR; Gross RA; Miller DC
Neurology; 1984 Dec; 34(12):1611-5. PubMed ID: 6390250
[TBL] [Abstract][Full Text] [Related]
55. [Human cancer antigens].
Burtin P
Ann Biol Clin (Paris); 1972; 30(2):95-7. PubMed ID: 4339238
[No Abstract] [Full Text] [Related]
56. Biochemical and immunologic diagnosis of cancer. Central nervous system tumors.
Collins VP
Tumour Biol; 1987; 8(2-3):147-50. PubMed ID: 3329397
[No Abstract] [Full Text] [Related]
57. [Granulocyte colony stimulating factor (G-CSF) in diagnosis and monitoring of non-small-cell lung cancer (NSCLC)].
Mroczko B; Szmitkowski M; Czygier M
Pol Arch Med Wewn; 2000; 103(3-4):163-8. PubMed ID: 11236243
[TBL] [Abstract][Full Text] [Related]
58. Granulocyte-Colony stimulating factor and macrophage-colony stimulating factor in patients with non-small-cell lung cancer.
Mroczko B; Szmitkowski M; Niklinski J
Clin Chem Lab Med; 2001 May; 39(5):374-9. PubMed ID: 11434384
[TBL] [Abstract][Full Text] [Related]
59. Biomarkers define distinct types of diffuse glioma.
Cancer Discov; 2015 Aug; 5(8):787. PubMed ID: 26134050
[TBL] [Abstract][Full Text] [Related]
60. Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients.
Akiyama Y; Komiyama M; Miyata H; Yagoto M; Ashizawa T; Iizuka A; Oshita C; Kume A; Nogami M; Ito I; Watanabe R; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Yamaguchi K
Oncol Rep; 2014 Apr; 31(4):1683-90. PubMed ID: 24573400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
